COVID-19
Weekly Updates

As the novel Coronavirus, COVID-19 sweeps the globe and garners massive media attention, Parasites Without Borders staff are curating resources in a timely ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains, to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

MicrobeTV_Group_REV02

Throughout November, December, And January,
All Donations Made To Parasites Without Borders
Will Be Matched By PWB And Donated To MicrobeTV.

UnitedInResearch_Logo_white_small2

COVID-19 Testing Strategy Simulator

There are many strategies that will reduce infection in your population. Any testing will reduce your disease burden. Using this tool to compare pooling, test accuracy, testing frequency, and costs will allow you to choose the strategy best suited to your needs and your community.

Male warehouse employee moving inventory while wearing a medical mask

January 5, 2022

CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population | Children and COVID-19: State-Level Data Report | Texas Children’s Hospital and Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization in India
Man wearing mask while in a track suit with a child next to him both looking out of a window

December 27, 2021

Children and COVID-19: State Data Report | Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study | Quarantine and Isolation | Frequently Asked Questions on the Emergency Use Authorization for Paxlovid for Treatment of COVID-19

December 20, 2021

• Outpatient COVID-19 Management Strategies in Children and Adolescents • SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies • Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity • Azithromycin in patients with COVID-19: a systematic review and meta-analysis • Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 • In non–critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support • Africa's COVID-19 numbers surge, but hospital cases stay low • B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes • mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant • Protection against Covid-19 by BNT162b2 Booster across Age Groups
Vaccine protection for US Veterans and Military personnel

November 15, 2021

• SARS-CoV-2 vaccine protection and deaths among US veterans • New phase 3 analyses show that a single dose of REGEN-CoV (Casirivimab and Imdevimab) provides long-term protection against COVID-19 • Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death
Distraught Healthcare worker

October 29, 2021

• WHO estimate: 115,000 health workers have died from Covid-19, as calls for vaccine access grow • Virologic features of SARS-CoV-2 infection in children • COVID-19 Vaccination and Non–COVID-19 Mortality Risk • Association of Statins and 28-Day Mortality in Patients Hospitalized with SARS CoV-2 Infection • Assessment of Cognitive Function in Patients After COVID-19 Infection • Covid-19 Breakthrough Infections in Vaccinated Health Care Workers • Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines • FACT SHEET FOR HEALTH CARE PROVIDERS: EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COV • Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial • Routine Vaccination Coverage — Worldwide, 2020 Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication • The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity

October 22, 2021

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 | Comprehensive antibody profiling of mRNA vaccination in children | Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report | WHO, UN set out steps to meet world COVID vaccination targets

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

1280px-US_CDC_logo.svg

Centers for Disease Control, US

ProMED-Logo

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top